Zeposia Trademark Details

This mark is alive with a status of Non-Final Action - Mailed. The last case file activity for this mark occured 7 years ago on Friday, August 12, 2016, according to the United State Patent & Trademark Office
Word Mark Zeposia
Status Alive 641 — Non-Final Action - Mailed

Current Owner

Celgene Corporation of Summit, NJ

View all trademarks for Celgene Corporation
Other Trademarks for Celgene Corporation
Serial Number 86959853
Status Date Friday, August 12, 2016
Filing Date Friday, August 12, 2016
Attorney Camille M. Miller

Correspondent

CAMILLE M. MILLER
COZEN O'CONNOR
1650 MARKET STREET
SUITE 2800
PHILADELPHIA, PA 19103

Case File Statements

Goods & Services Pharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, multiple sclerosis, ulcerative colitis, arthritis, musculoskeletal and skin diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
Translation of Words in Mark The wording "ZEPOSIA" has no meaning in a foreign language.

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Tuesday, April 5, 2016
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.